NCT05071482 2025-05-01
Flumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALL
Institute of Hematology & Blood Diseases Hospital, China
Phase 4 Terminated
Institute of Hematology & Blood Diseases Hospital, China
Jiangsu Hansoh Pharmaceutical Co., Ltd.